Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity
- 29 March 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 678 (1), 113-128
- https://doi.org/10.1016/0378-4347(95)00574-9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- N‐acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients [letter]British Journal of Clinical Pharmacology, 1994
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994
- Altered patterns of drug metabolism in patients with acquired immunodeficiency syndromeClinical Pharmacology & Therapeutics, 1993
- The use of caffeine for enzyme assays: A critical appraisalClinical Pharmacology & Therapeutics, 1993
- Metabolic polymorphismsPharmacology & Therapeutics, 1993
- Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymesChemical Research in Toxicology, 1991
- Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodeneChemical Research in Toxicology, 1990
- Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenClinical Pharmacology & Therapeutics, 1989
- THE ROLE OF NUTRITION IN TOXICOLOGYAnnual Review of Nutrition, 1981